Drug Shortage Report for ROBITUSSIN AC
| Report ID | 96287 |
| Drug Identification Number | 01934740 |
| Brand name | ROBITUSSIN AC |
| Common or Proper name | Guaifenesin, Codeine Phosphate and Pheniramine Maleate Syrup |
| Company Name | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CODEINE PHOSPHATE GUAIFENESIN PHENIRAMINE MALEATE |
| Strength(s) | 10MG 100MG 7.5MG |
| Dosage form(s) | SYRUP |
| Route of administration | ORAL |
| Packaging size | 1 Litre |
| ATC code | R05FA |
| ATC description | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-10-09 |
| Estimated end date | 2020-01-31 |
| Actual end date | 2020-01-03 |
| Shortage status | Resolved |
| Updated date | 2020-11-12 |
| Company comments | Manufacturing disruption has been rectified. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 55 STANDISH COURT MISSISSAUGA, ONTARIO CANADA L5R 4B2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-11-12 | French | Compare |
| v3 | 2020-11-12 | English | Compare |
| v2 | 2019-10-11 | French | Compare |
| v1 | 2019-10-11 | English | Compare |
Showing 1 to 4 of 4